Aquestive Therapeutics (AQST) Asset Utilization Ratio (2018 - 2026)

Aquestive Therapeutics' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.04 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 91.7% year-over-year to 0.04; the TTM figure through Mar 2026 stood at 0.04 (down 91.7% YoY), while the FY2025 annual figure was 0.01, down 99.01% from the prior year.
• Asset Utilization Ratio was 0.04 for Q1 2026 at Aquestive Therapeutics, up from 0.01 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.87 in Q4 2023 to a low of 0.01 in Q4 2025.
• Historically, Asset Utilization Ratio has averaged 0.57 across 5 years, with a median of 0.55 in 2024.
• The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio jumped 131.58% in 2022, then slumped 98.94% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.78 in 2022, then grew by 11.14% to 0.87 in 2023, then slumped by 37.09% to 0.54 in 2024, then plunged by 98.94% to 0.01 in 2025, then surged by 663.3% to 0.04 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.04 (Q1 2026), 0.01 (Q4 2025), and 0.34 (Q3 2025), per Business Quant data.